GBP3 in glioblastoma upregulates MGMT to repair temozolomide-induced DNA damage, preserving tumor viability and counteracting alkylating agent efficacy, a process facilitated by its diffuse cytoplasmic distribution and GTPase activity [33]. This evidence concerns the gene GBP3 and glioblastoma.